Lilly starts the trend to limit 340B pricing to contract pharmacies
September 1, 2020
Lilly starts the trend to limit 340B pricing to contract pharmacies. Other drug manufacturers follow including Sanofi, Merck, AstraZeneca, United Therapeutics, Novartis, Novo Nordisk See